Case 2
A 20-year-old African American woman with NDCM, HFrEF of 20%, and diabetes mellitus presented in acute decompensated heart failure thirteen months after ICD placement (EF 5%, NYHA Class IV, Stage D). Impella 5.5 (Abiomed, Danvers, MA) was implanted. She was listed UNOS status 1. Ten weeks later, she underwent transplant after she/donor tested SARS-CoV-2 negative. Standard immunosuppression was implemented after induction with rabbit anti-thymocyte globulin and mycophenolate mofetil. On postoperative day ten, she was discharged home following an uncomplicated hospital course. She continues to progress well. Eight months postoperatively, she has consistently tested negative for SARS-CoV-2, with no evidence of rejection.